ArticleMolecular diversity2026
TripleBind: a generalizable deep learning framework for protein-nucleic acid and protein-ligand binding sites prediction based on pre-trained protein language models.
Article in Molecular diversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-nucleic acid and protein-ligand interactions play important roles in regulating cellular processes and form a fundamental foundation for drug discovery and design. Although existing experimental assays can yield highly accurate measurements, they are often labor-intensive, costly, and insufficient to meet the rapidly growing demand for large-scale protein sequence annotation.Consequently, developing an efficient and reliable computational framework capable of accurately identifying protein-nucleic acid and protein-ligand binding residues has become crucial. In this study, we present TripleBind, a new deep learning architecture that predicts protein-nucleic acid and protein-ligand binding sites using sequence information alone. TripleBind integrates three Transformer-based pre-trained protein language models with a specially designed Multi-Branch Convolutional Network (MBCN) module. Experimental results on protein-nucleic acid benchmark datasets demonstrate that our method achieves MCC scores of 0.392 and 0.512 on independent protein-DNA test sets, and an MCC of 0.46 on an independent protein-RNA test set, shows improved performance compared with existing sequence-based methods. In addition, TripleBind can serve as a general predictor of protein-ligand interactions and exhibits robust performance across different tasks. Finally, we provide interpretability analyses to elucidate the behavior of our model and summarize its overall contributions.
Indexed as
Identifiers
42012716What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.